5 Dow Jones Stocks Fell Over 10% in 2025. Here's Why They Are All Contrarian Buys for 2026.

Core Insights - The consumer staples sector, including Procter & Gamble, has faced challenges in 2025, with Procter & Gamble managing to maintain high margins through diversification and strong supply chain management [1][3][7] - Tariffs are complicating supply chains and pressuring margins, making it difficult for consumer staples companies to pass costs onto consumers [2] - The consumer staples sector is underperforming the S&P 500, with a decline of 0.4% compared to a 17.8% gain in the index [3] Procter & Gamble - Procter & Gamble continues to grow earnings, albeit at a slower pace, and maintains a reliable dividend with 69 consecutive years of increases and a yield of 2.9% [7] Home Depot - Home Depot's stock is trading at 24.1 times forward earnings, with a dividend yield of 2.7%, making it an attractive option for value investors [4][5] - The company has been investing in long-term growth through acquisitions and new store openings, positioning itself for future recovery [4] - Home Depot's performance is closely tied to consumer sentiment and spending on home improvement projects, which are currently under pressure [5] Nike - Nike is facing significant challenges, including tariffs impacting gross margins and a competitive landscape that has eroded its dominance [8][9] - The company is adapting its strategy to focus on storytelling and innovation to resonate with consumers [9][10] - Despite difficulties, Nike's stock may be worth considering for long-term investors, with a dividend yield of 2.7% [10] Salesforce - Salesforce has experienced a sell-off due to concerns about the SaaS model in the age of AI, but it is taking proactive steps to enhance its offerings [11][12] - The company has high margins and is trading at 22.6 times forward earnings, making it an attractive buy for long-term investors [14] UnitedHealth - UnitedHealth has faced significant challenges, including a loss of roughly one-third of its value in 2025, but it is positioned for recovery [15][16] - The company is increasing premiums to adjust for rising costs, with a forward earnings multiple of 20.3 and a dividend yield of 2.7% [18]